CASI Pharmaceuticals Inc (NASDAQ: CASI) stock closed at $5.66 on 3/5/24 after a major increase of 11.3%. Moreover, trading volume in this advance was exceptionally high at 4069% of normal. The stock has risen 4.0% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, CASI is expected to continue to be a modest Value Eraser.
CASI Pharmaceuticals has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. CASI Pharmaceuticals has a poor Appreciation Score of 15 but a very high Power Rating of 98, leading to the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment